Login / Signup

Targeting the RANK/RANKL pathway in autoimmune disease and malignancy: future perspectives.

Ana LleoMerrill Eric Gershwin
Published in: Expert review of clinical immunology (2021)
Keyphrases
  • multiple sclerosis
  • cancer therapy
  • nuclear factor
  • bone loss
  • immune response
  • toll like receptor